secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0001628280-24-000993
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Health reaffirms 2023 guidance; 2024 revenue $1.45B-$1.55B, positive EBITDA $20M-$40M
--------------------------------------------------------------------------------

- FY2023 reaffirmed: revenue $1.2B-$1.25B, medical margin $155M-$175M, Adj. EBITDA loss $30M-$50M.
- FY2024 guidance: revenue $1.45B-$1.55B, medical margin $230M-$250M, Adj. EBITDA positive $20M-$40M.
- Medicare Advantage members expected 125k-135k in 2024, up from 115k-120k in 2023.
- Medical margin PMPM guided $165-$175 in 2024, up from $120-$130 in 2023.
- Management expects meaningful profitability in 2024, citing robust pipeline and managed cost trend.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000162828024000993/0001628280-24-000993-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000162828024000993/piii-20240109.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-000993

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer